Mergers and acquisitions in pharma and biotech
Mergers and acquisitions in pharmaceutical and biotechnology are strategic maneuvers that reshape the industry landscape to foster innovation, expand research capabilities and increase market competitiveness. These collaborations and consolidations enable companies to pool resources, share expertise and accelerate the development of new drugs and medical technologies.
Top Stories
-
News
02 Aug 2024
AbbVie acquires Cerevel Therapeutics for $45 per share
AbbVie is expanding its neuroscience portfolio through its acquisition of Cerevel Therapeutics. Continue Reading
-
News
08 Jul 2024
Eli Lilly to acquire Morphic Holding Inc. in a $3.2 billion deal
If the acquisition goes through, it will support and enhance Eli Lilly’s inflammatory bowel disease portfolio. Continue Reading
-
News
03 Jul 2024
Biden, Sanders push for lower prescription drug costs for GLP-1 medications
Biden and Sanders intensified efforts to lower prescription drug prices, spotlighting the high costs of GLP-1 receptor agonists like Ozempic and Wegovy. Continue Reading
-
News
29 May 2024
Johnson & Johnson agrees to acquire Yellow Jersey Therapeutics
The acquisition will give the company rights to a clinical-stage antibody treatment for atopic dermatitis. Continue Reading
-
News
20 Mar 2024
AstraZeneca acquires Fusion Pharmaceuticals in $2 billion deal
The acquisition provides AstraZeneca with access to clinical-stage, next-generation radioconjugates for oncology. Continue Reading
-
News
15 Feb 2024
Gilead Announced Plans to Acquire CymaBay in a $4.3 Billion Deal
Gilead announced plans to acquire CymaBay in a $4.3 billion deal to expand the company’s liver disease portfolio. Continue Reading
-
News
06 Dec 2023
Roche Expands Obesity Portfolio Through $2.7 Billion Carmot Acquisition
On Monday, Roche announced that it had entered into a definitive merger agreement to acquire Carmot Therapeutics for $2.7 billion upfront. Continue Reading
-
News
11 Sep 2023
Abbott Plans to Acquire Bigfoot Biomedical, Growing Diabetes Portfolio
This acquisition, anticipated in the third quarter of 2023, is defined by Bigfoot’s FDA-cleared smart insulin management system. Continue Reading
-
News
23 Jun 2023
Eli Lilly Announces $2.4B Acquisition of Immunology Company Dice Therapeutics
The pharma giant will expand its immunology portfolio with a new oral molecule pipeline. Continue Reading
-
News
25 May 2023
FTC’s Lawsuit Against Amgen Horizon Deal to Reach Court in September
The legal challenge is a rare move that may spell trouble for future pharmaceutical M&A activity. Continue Reading
-
News
19 Apr 2023
GSK Acquires Bellus Health for $2 Billion
The pharmaceutical acquisition will yield one of the few treatments for chronic cough with immediate FDA approval potential. Continue Reading
-
News
18 Apr 2023
Merck Plans to Acquire Prometheus Biosciences in a $10.8 Billion Deal
Merck announced plans to acquire Prometheus Biosciences and expand its immunology portfolio in a $10.8 billion deal. Continue Reading
-
News
16 Mar 2023
Sanofi Acquires Provention Bio for $2.9 Billion
Paris-based Sanofi announced its acquisition just months after Provention’s TZIELD monoclonal antibody was approved in the United States. Continue Reading
-
Feature
15 Mar 2023
A Closer Look at the Most Recent Pfizer Acquisition Deal: Seagen Inc
Considering the hefty price tag on the most recent Pfizer acquisition deal, pharmaceutical industry leaders may benefit from a closer look at Seagen and why it’s appealing. Continue Reading
-
News
13 Mar 2023
Pfizer Confirms $43B Seagen Acquisition Deal
In this morning’s press announcement, Pfizer confirmed a $43 billion definitive acquisition deal with Seagen, expanding its oncology medicines portfolio. Continue Reading
-
News
02 Mar 2023
Pfizer Considers Potential $40B Seagen Acquisition
News broke over the weekend that Pfizer was eyeing the massive purchase of Washington-based Seagen. Continue Reading
-
News
16 Feb 2023
Sun Pharmaceutical Industries Acquires Concert Pharma for $576M
India’s top pharmaceutical company will acquire Massachusetts-based Concert Pharmaceuticals and its experimental drug for alopecia. Continue Reading
-
News
09 Feb 2023
Envision Pharma Group Acquires OKRA.ai
Global pharma solutions partner Envision Pharma will add OKRA.ai to its platform this month, building on its suite of pharma applications. Continue Reading
-
News
02 Feb 2023
Senator Targets Amgen and Indivior Acquisitions for Antitrust Action
In a letter to the FTC, Senator Elizabeth Warren expressed concern that the two pharmaceutical acquisitions were anti-competitive and could lead to higher drug prices. Continue Reading
-
News
19 Jan 2023
Pfizer Acquires Abzena’s Biologic Manufacturing Facility
The planned addition of the complex biologics manufacturing facility will bring Pfizer’s North Carolina footprint up to 4,500 employees by 2025. Continue Reading
-
News
12 Jan 2023
AstraZeneca Purchases CinCor Pharma Inc. in $1.8 Billion Acquisition
AstraZeneca will build on its heart and kidney business, acquiring CinCor Pharma, an industry leader in pharmaceuticals for cardiorenal diseases. Continue Reading
-
News
05 Jan 2023
Moderna to Buy Japanese Firm OriCiro in Its First-Ever Acquisition
In its inaugural acquisition, Moderna will buy the Japanese biotechnology company OriCiro Genomics and obtain its suite of genetic engineering tools. Continue Reading
-
News
15 Dec 2022
Amgen’s $27.8 Billion Rare Disease Drug Acquisition
The pharmaceutical heavyweight Amgen Inc will acquire Horizon Therapeutics PLC for nearly $28 billion in cash, closing out the year with one of pharma's largest buyouts. Continue Reading
-
News
02 Dec 2022
Eli Lilly Acquires Akouos in Approximately $487 Million Transaction
On December 1, 2022, Eli Lilly announced that it had completed the acquisition of Akouos after announcing the $487 million deal to accelerate gene therapies earlier this year on October 18, 2022. Continue Reading
-
News
17 Nov 2022
Citeline and Norstella Merger Creates $5B Pharmaceutical Technology Company
The two companies completed their merger this month, combining their resources to simplify the clinical trial process for pharmaceutical companies and life sciences firms. Continue Reading
-
News
10 Nov 2022
J&J Preps for Consumer Health Spin-Off, Purchases Abiomed for $16.6B
The pharmaceutical and consumer health giant will buy heart pump maker Abiomed for nearly $17 billion as part of its new growth strategy. Continue Reading
-
News
22 Sep 2022
Walgreens' $1.67-Billion Specialty Pharmacy and Home Health Play
Walgreens Boots Alliance has bought a controlling stake in home health brand CareCentrix and finished its acquisition of specialty pharmacy company Shields Health Solutions for a total of $1.67 billion. Continue Reading
-
News
20 Sep 2022
McKesson Plans to Acquire Rx Savings Solutions
In a recent press release, McKesson announced its plans to acquire Rx Savings Solutions to advance access, affordability, and adherence solutions initiatives. Continue Reading
-
News
11 Aug 2022
Pfizer Buys Global Blood Therapeutics for $5.4B, Continues Acquisition Splurge
Pfizer will shell out $5.4 billion in cash to bring in Global Blood Therapeutics and its sickle cell disease treatment. Continue Reading
-
News
04 Aug 2022
Merck & Co.'s $40B Acquisition of Pharmaceutical Company Seagen
The acquisition of Seagen would support Merck’s oncology business after they lose exclusivity to their cash cow Keytruda. Continue Reading
-
News
23 Jun 2022
Pfizer Acquires ReViral for $525M, Renews Pharma Acquisition Spree
Another pharmaceutical acquisition sees Pfizer bring in RSV antiviral creator ReViral, adding to the companies growing list of subsidiaries. Continue Reading
-
News
24 May 2022
Pfizer Acquires Biohaven Pharmaceutical for $11.6 Billion in Cash
After years of collaboration on several innovative treatments, Pfizer will acquire the smaller pharma company. Continue Reading
-
News
28 Mar 2022
Sandoz Acquires Drug Delivery Device Company to Boost Pipeline
Sandoz acquired the capabilities and assets of drug delivery device company, Coalesce, to further its existing portfolio of respiratory medicines and improve overall patient access. Continue Reading
-
News
10 Jan 2022
Thermo Fisher Acquires PeproTech to Boost Gene Therapy Market
PeproTech will increase Thermo Fisher Scientific’s capabilities in the gene therapy market and add new capabilities to its existing biotech offerings. Continue Reading
-
News
20 Dec 2021
Pfizer to Acquire Arena to Boost Chronic Disease Management
Pfizer will acquire Arena Pharmaceuticals to enhance chronic disease management, including accelerating development of etrasimod for patients with immuno-inflammatory diseases. Continue Reading
-
News
02 Dec 2021
Novo Nordisk Enters Pharma Acquisition Deal For RNAi Therapies
Novo Nordisk’s pharma acquisition deal with Dicerna Pharmaceuticals supports the strategy of using a broad range of technology platforms for various RNAi therapies. Continue Reading
-
News
14 Oct 2021
Merck Enters Into $11.5B Deal to Boost Cardiovascular Pipeline
Acceleron Pharma’s therapeutic candidates complement and strengthen Merck’s growing cardiovascular pipeline. Continue Reading
-
News
11 Oct 2021
AstraZeneca Acquires Caelum Biosciences For Rare Disease Antibody
Researchers are currently studying the antibody combined with standard of care therapy for rare disease AL amyloidosis in a Phase 3 clinical program. Continue Reading
-
News
15 Sep 2021
Roche Acquires TIB Molbiol to Boost Molecular Diagnostics Profile
The acquisition will enhance Roche’s molecular diagnostics solutions portfolio with a wide range of assays for infectious diseases, including the SARS-CoV-2 variants. Continue Reading
-
News
14 Sep 2021
Sanofi Inks $1.9B Pharma Acquisition Deal with Kadmon Holdings
Under the pharma acquisition deal, Sanofi will continue to grow its General Medicines core assets and add Kadmon’s chronic graft-versus-host disease treatment, Rezurock, to its portfolio. Continue Reading
-
News
08 Sep 2021
Premier, Top Health Systems Acquire Exela to Combat Drug Shortages
Premier and participating member health systems signed a multi-year commitment to purchase a portion of their pharmaceutical products from Exela, tackling drug shortages in the US. Continue Reading
-
News
25 Aug 2021
Pfizer Enters Acquisition Deal for Immuno-Therapeutics Pipeline
Under the terms of the agreement, Pfizer will acquire all outstanding shares of Trillium for a total of $2.26 billion and strengthen its immuno-therapeutics pipeline for hematological malignancies. Continue Reading
-
News
11 Aug 2021
Bayer Enters Pharma Acquisition Deal for Undruggable Targets
Bayer will use Vividion’s drug discovery platform to produce various small molecule therapies for undruggable targets. Continue Reading
-
News
05 Aug 2021
Sanofi, Translate Enter Pharma Acquisition Deal for mRNA Vaccines
Translate Bio will provide its mRNA technology platform and other capabilities to Sanofi’s research, advancing the development of mRNA vaccines and therapeutics. Continue Reading
-
News
03 Aug 2021
Amgen Enters Pharma Acquisition Deal to Develop New Biologics
The pharma acquisition deal aims to innovate medicines and new biologics to treat patients with serious illness and bring to market products across core therapeutic areas. Continue Reading
-
News
21 Jul 2021
BioNTech to Acquire Kite’s TCR Platform for Cell Therapy Pipeline
Kite’s R&D platform will provide capacity for clinical trials in the US and support BioNTech’s growing cell therapy pipeline, which includes promising cancer candidates. Continue Reading
-
News
20 Jul 2021
Eli Lilly Enters Pharma Acquisition Deal for Diabetes Treatment
Eli Lilly will provide its diabetes treatment pipeline and Protomer Technologies will leverage its glucose-sensing insulin to boost therapies for diabetes patients. Continue Reading
-
News
28 Jun 2021
uniQure Inks Gene Therapy Acquisition Deal with Corlieve Therapeutics
The Netherlands-based gene therapy company will lead Corlieve Therapeutics’ program, AMT-260, to treat temporal lobe epilepsy. Continue Reading
-
News
08 Jun 2021
Bayer Inks Pharma Acquisition Deal to Advance Cancer Therapies
As part of the pharma acquisition deal, Bayer will gain exclusive rights to a differentiated alpha radionuclide investigational compound based on actinium-225. Continue Reading
-
News
03 May 2021
Pfizer Acquires Amplyx to Grow Anti-Infective Therapies Pipeline
Pfizer secured Amplyx’s early-stage therapies, including potential antivirals and antifungals to boost its anti-infective therapies pipeline. Continue Reading
-
News
12 Apr 2021
Hologic Acquires Molecular Diagnostic Test Developer for $795M
The acquisition will accelerate global growth of Mobidiag’s molecular diagnostic test platforms, which offer ease of use, multiplex capability, and rapid turnaround time, Hologic said. Continue Reading
-
News
23 Mar 2021
FTC Takes New Approach to Analyzing Pharmaceutical Mergers
A new working group is seeking to improve enforcement of pharmaceutical mergers and acquisitions and build new approaches to analyze and address competitive concerns. Continue Reading
-
News
18 Mar 2021
Amgen Acquires Five Prime in $1.9B Pharma Acquisition Deal
The pharma acquisition deal adds Five Prime’s innovative pipeline to Amgen’s immuno-oncology and targeted cancer therapies portfolio. Continue Reading
-
News
29 Jan 2021
Novavax COVID-19 Vaccine 89% Effective Against UK COVID-19 Strain
The COVID-19 vaccine candidate was also found to be 95.6% effective against the original COVID-19 strain found in Wuhan, China. Continue Reading
-
News
27 Jan 2021
Thermo Fisher Inks $450M Deal to Acquire Mesa Biotech
Mesa Biotech's rapid PCR-based test will help Thermo Fisher Scientific meet the continued demand for COVID-19 testing and advance molecular diagnostics tests at the point of care, the company said. Continue Reading
-
News
29 Dec 2020
Eli Lilly Signs $800M Deal to Acquire Prevail Therapeutics
The pharmaceutical acquisition deal will allow Eli Lilly to establish a gene therapy program and broaden its commitment to novel modalities, anchored by Prevail’s portfolio of neuroscience assets. Continue Reading
-
News
24 Dec 2020
AstraZeneca to Acquire Alexion in $39B Pharma Deal
AstraZeneca’s acquisition with rare disease specialist, Alexion Pharmaceuticals, is expected to double its revenue growth through 2025 and bring greater scientific presence to immunology. Continue Reading
-
News
09 Nov 2020
Merck Signs $2.75B Pharma Acquisition Deal with VelosBio
The pharma acquisition deal will give Merck access to VelosBio’s antibody-drug conjugates, strengthening the company’s oncology pipeline. Continue Reading
-
News
28 Oct 2020
Bayer Inks $4B Pharma Acquisition Deal to Boost Gene Therapy Base
The pharma acquisition deal will provide Bayer with full rights to AskBio’s gene therapy platform and bring urgently needed treatments to patients across multiple disease areas. Continue Reading
-
News
07 Oct 2020
Johnson & Johnson Completes $6.5B Pharma Acquisition Deal
Other recent pharma acquisition deals include Bristol Myers Squibb’s acquisition of MyoKardia for $13.1 billion and Sanofi’s acquisition of Principia Biopharma for $3.68 billion. Continue Reading
-
News
02 Sep 2020
Pharmaceutical M&A Activity Increased 17% in First Half of 2020
Pharmaceutical M&A activity is surprisingly up so far this year despite the economic downturn brought on by the COVID-19 pandemic, a new report shows. Continue Reading
-
News
25 Aug 2020
Johnson & Johnson Buys Momenta in $6.5B Pharma Acquisition Deal
The pharma acquisition deal will provide Johnson & Johnson with the opportunity to broaden its expertise in immune-mediated diseases and expand into autoantibody-driven disease. Continue Reading
-
News
20 Aug 2020
Sanofi Inks $3.4B Pharma Acquisition Deal with Principia Biopharma
The pharma acquisition deal will strengthen Sanofi’s research and development efforts for autoimmune and allergic diseases, as well as provide more control of BTK inhibitors. Continue Reading
-
News
19 Aug 2020
Bristol Myers Squibb Pays $475M to Acquire Immunotherapy Program
The deal will bring Dragonfly Therapeutics’ immunotherapy program under Bristol Myers Squibb’s umbrella. Continue Reading
-
News
28 Jul 2020
Pharmaceutical Mergers, Acquisitions Down in First Half of 2020
There were only two major pharmaceutical merger and acquisition deals so far, but the potential for more activity is there, PwC reports. Continue Reading
-
News
02 Jul 2020
Gilead Will Acquire Equity in Pionyr Immunotherapeutics for $275M
Gilead will provide funding for Pionyr Immunotherapeutic’s clinical programs and will have the option to acquire the remainder of the company for $315 million option exercise fee. Continue Reading
-
News
07 May 2020
Lilly, Junshi Biosciences to Develop COVID-19 Antibody Therapies
The partnership will accelerate the development of COVID-19 antibody therapies, while an antibody test from another major pharma company is hitting the market. Continue Reading
-
News
02 Apr 2020
Mylan, Pfizer Delay Major Pharmaceutical Merger Due to COVID-19
The proposed pharmaceutical merger between Mylan and a division of Pfizer has been pushed back because of the ongoing COVID-19 pandemic. Continue Reading
-
News
28 Jan 2020
Biotech to be ‘Extremely Active’ in 2020 Mergers and Acquisitions
Biotech M&A will be “extremely active” this year and fuel pharma M&A, PwC says. Continue Reading
-
News
16 Jan 2020
2020 Poised to be Another Life Sciences M&A 'Mega' Year
Life sciences companies have $1.4 trillion in firepower at their disposal for 2020 mergers and acquisitions. Continue Reading
-
News
09 Jan 2020
FTC Thwarts $1.2B Illumina-Pacific Biosciences Takeover
Illumina and Pacific Biosciences of California terminated their $1.2 billion merger agreement over regulatory approval hurdles and continued uncertainty about the outcome. Continue Reading
-
News
18 Dec 2019
FTC Moves to Block Illumina Acquisition of PacBio, Citing Monopoly
FTC is challenging $1.2-billion biotechnology acquisition that the federal agency alleges will create a monopoly. Continue Reading
-
News
22 Nov 2019
Pharmaceutical Companies Made Acquisitions a Top Priority in 2019
Over the past year, the pharmaceutical industry has witnessed a flurry of merger and acquisition activity. Continue Reading